Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001897612-26-000288·Bicara Therapeutics Inc.
Schedule 13G ownership disclosure
Bicara Therapeutics Inc
COMMON STOCK · CUSIP: 055477103
Event date: 2025-12-31
- Filing-level shares
- 3,236,595
- Percent of class
- 5.9%
- T. Rowe Price Investment Management, Inc.
Shares: 3,236,595 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-26-000288
- Form type
- SCHEDULE 13G
- Filer
- Bicara Therapeutics Inc.
- CIK
- CIK 2023658
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership